Literature DB >> 7811175

Incidence of skin breakdown and higher amputation after transmetatarsal amputation: implications for rehabilitation.

M J Mueller1, B T Allen, D R Sinacore.   

Abstract

The purpose of this study of patients with transmetatarsal amputation (TMA) is to describe multiple patient characteristics, including the incidence of subsequent skin breakdown and higher amputation, that may influence rehabilitation treatment and outcomes. Data were gathered on all patients having a TMA at this facility between April 1989 and September 1993. One hundred twenty TMAs were performed on 107 patients with a mean age of 62.4 +/- 13.8 years. There were 55 men and 52 women. Thirteen patients (12%) had a bilateral TMA. Twenty-nine patients (27%) developed skin breakdown. Of these, 48% occurred within the first 3 months after surgery. Thirty patients (28%) required a higher amputation. Of these, 60% occurred in the first month after TMA. In addition, this group of patients had a high incidence of diabetes mellitus (77%), hypertension (54%), electrocardiogram (EKG) abnormalities (60%), congestive heart failure (22%), and prior ipsilateral vascular surgery (51%). These results indicate that patients with TMA often present with a complicated medical condition and that they are at high risk of skin breakdown or higher amputation, especially in the first 3 months after surgery. The investigators conclude that patients with TMA may benefit from a rehabilitation program emphasizing protection of the residuum during their return to functional activities. Additional research is needed to determine optimal acute and long-term rehabilitation of patients with TMA.

Entities:  

Mesh:

Year:  1995        PMID: 7811175     DOI: 10.1016/s0003-9993(95)80042-5

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Transmetatarsal amputation: an 8-year experience.

Authors:  S R Thomas; J M Perkins; T R Magee; R B Galland
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

2.  Re-amputation occurrence in the diabetic population in South Wales, UK.

Authors:  Rajani Kanade; Robert van Deursen; Jo Burton; Vanessa Davies; Keith Harding; Patricia Price
Journal:  Int Wound J       Date:  2007-10-24       Impact factor: 3.315

3.  Application of gentamicin-collagen sponge shortened wound healing time after minor amputations in diabetic patients - a prospective, randomised trial.

Authors:  Martin Varga; Bedrich Sixta; Robert Bem; Ivan Matia; Alexandra Jirkovska; Milos Adamec
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

4.  Review of Transmetatarsal Amputations in the Management of Peripheral Arterial Disease in an Asian Population.

Authors:  Ming Ngan Aloysius Tan; Zhiwen Joseph Lo; Soon Hong Lee; Rui Ming Teo; Wei Leong Glenn Tan; Sadhana Chandrasekar
Journal:  Ann Vasc Dis       Date:  2018-06-25

5.  Clinical Characteristics, Quality of Life, and Risk Factors of Amputation Stump Skin Disease and Stump Fungal Infection in Adult Amputees in Shanghai, China.

Authors:  Yanqiao Li; Longwen He; Xiangting Lu; Qian Du; Shijun Yu; Xin Huang
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

6.  Transmetatarsal Amputation Results in Higher Frequency of Revision Surgery and Higher Ambulation Rates Than Below-Knee Amputation.

Authors:  Angel Ordaz; Conner Trimm; Jason Pedowitz; Ian M Foran
Journal:  Foot Ankle Orthop       Date:  2022-07-21

7.  Describe the outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review protocol for the development of shared decision-making resources.

Authors:  Michael P Dillon; Stefania Fatone; Matthew Quigley
Journal:  Syst Rev       Date:  2015-12-04

Review 8.  Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources.

Authors:  Michael P Dillon; Matthew Quigley; Stefania Fatone
Journal:  Syst Rev       Date:  2017-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.